As of 2025-07-12, the Intrinsic Value of Incyte Corp (INCY) is 22.63 USD. This Incyte valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 68.59 USD, the upside of Incyte Corp is -67.00%.
The range of the Intrinsic Value is 20.25 - 23.64 USD
Based on its market price of 68.59 USD and our intrinsic valuation, Incyte Corp (INCY) is overvalued by 67.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (21.86) - 0.66 | (4.64) | -106.8% |
| DCF (Growth 10y) | 1.11 - (17.50) | (3.32) | -104.8% |
| DCF (EBITDA 5y) | 20.25 - 23.64 | 22.63 | -67.0% |
| DCF (EBITDA 10y) | 19.38 - 24.77 | 22.74 | -66.8% |
| Fair Value | 2.75 - 2.75 | 2.75 | -95.99% |
| P/E | 1.42 - 38.77 | 10.22 | -85.1% |
| EV/EBITDA | 22.36 - 29.58 | 26.79 | -60.9% |
| EPV | 26.73 - 31.86 | 29.29 | -57.3% |
| DDM - Stable | 1.19 - 4.96 | 3.07 | -95.5% |
| DDM - Multi | 18.58 - 61.28 | 28.63 | -58.3% |
| Market Cap (mil) | 13,276.97 |
| Beta | 0.42 |
| Outstanding shares (mil) | 193.57 |
| Enterprise Value (mil) | 10,905.43 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.24% |
| Cost of Debt | 5.00% |
| WACC | 8.22% |